Top Markets
Coin of the day
Entheon Biomedical Corp. Entheon Biomedical Corp.

Entheon Biomedical Corp.

ENBI
Rang in Aktien #38405
Entheon Biomedical Corp. functions as a biotechnology firm focused on the... Entheon Biomedical Corp. functions as a biotechnology firm focused on the research and development of novel pharmaceuticals. The company is actively involved in pioneering and introducing to market psychedelic therapeutic products, specifically those derived from N,N-dimethyltryptamine (DMT), with the aim of combating addiction and various substance use disorders. Its services are provided to medical doctors, healthcare facilities, and accredited psychiatrists across Canada, the United States, and the European Union. Entheon Biomedical Corp.'s primary operations are based in Vancouver, Canada.
Aktienkurs
$0.0719818
Zuletzt synchronisiert: 2026-01-15
Marktkapitalisierung
$997.59K
Veränderung (1 Tag)
-0.09%
Veränderung (1 Jahr)
4.67%
Land
CA
Handel Entheon Biomedical Corp. (ENBI)

Kategorie

Dividendenrendite-Verlauf für Entheon Biomedical Corp. (ENBI)
Dividendenrendite (TTM) von Entheon Biomedical Corp. (Aktienkürzel: ENBI) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Entheon Biomedical Corp. (ENBI) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber